Publications by authors named "Soongyu Choi"

Claim this Profile
S
SAR studies toward discovery of emvododstat (PTC299), a potent dihydroorotate dehydrogenase (DHODH) inhibitor.
Ramil Y Baiazitov, Hongyan Qi, Tamil Arasu, William Lennox, Liangxian Cao, Soongyu Choi

Eur J Med Chem· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Novel Small-Molecule Antiangiogenesis Agents to Treat Diabetic Retinopathy.
Donghwa Kim, Sang Won Choi, Jihee Cho, Jae-Hui Been, Kyoungsun Choi, Soongyu Choi

J Med Chem· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non-Small Cell Lung Cancer.
Jiyeon Yun, Min Hee Hong, Seok-Young Kim, Chae-Won Park, Soyoung Kim, Soongyu Choi

Clin Cancer Res· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Optimization of Small Molecule Splicing Modifiers of Survival Motor Neuron 2 as a Treatment for Spinal Muscular Atrophy.
Matthew G Woll, Hongyan Qi, Anthony Turpoff, Nanjing Zhang, Xiaoyan Zhang, Soongyu Choi

J Med Chem· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of imidazole amide derivatives as cannabinoid-1 receptor antagonists for the treatment of obesity.
Roger A Smith, Zahra Fathi, Furahi Achebe, Christiana Akuche, Su-Ellen Brown, Soongyu Choi

Bioorg Med Chem Lett· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Constrained analogs of CB-1 antagonists: 1,5,6,7-Tetrahydro-4H-pyrrolo[3,2-c]pyridine-4-one derivatives.
Roger A Smith, Zahra Fathi, Su-Ellen Brown, Soongyu Choi, Jianmei Fan

Bioorg Med Chem Lett· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17beta-hydroxysteroid dehydrogenase. Part 3. Identification of lead candidate.
Jill Wood, Cedo M Bagi, Christiana Akuche, Antonietta Bacchiocchi, Jeremy Baryza, Soongyu Choi

Bioorg Med Chem Lett· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17beta-hydroxysteroid dehydrogenase. Part 2. SAR.
David Gunn, Christiana Akuche, Jeremy Baryza, Marie-Louise Blue, Catherine Brennan, Soongyu Choi

Bioorg Med Chem Lett· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospects for kinase activity modulators in the treatment of diabetes and diabetic complications.
William H Bullock, Steven R Magnuson, Soongyu Choi, David E Gunn, Joachim Rudolph

Curr Top Med Chem· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis